The gain-of-function mutation c.617G>A (Arg206His) in the ACVR1 gene was the first to be reported and is the most common mutation in FOP patients (more than 95% of the cases). This evidence concerns the gene ACVR1 and fibrodysplasia ossificans progressiva.